Table 2.
Median cost of HBV-related care across healthcare facilities in Ghana
| Subsidized price with government health insurance USD Equivalenta Median (Range) |
Non-subsidized price without government health insurance USD Equivalenta Median (Range) |
|
|---|---|---|
| Diagnostics | ||
| HBsAg | 0.89 (0 – 1.94) | 2.91 (0.56 – 5.00) |
| HBV Profile | 3.15 (1.96 – 8.07)) | 7.26 (5.65 – 50.03) |
| HBV DNA | Not subsidized | 64.56 (48.42 – 67.79) |
| Liver Function | 3.23 (0 - 6.46) | 9.68 (8.07 – 12.91) |
| APRI | 4.23 (0 – 9.68) | 13.71 (2.42 – 16.14) |
| INR | Not subsidized | 8.47 (3.23 – 9.68) |
| Ultrasound | 3.39 (0 – 4.84) | 8.88 (6.46 – 19.34) |
| Abdominal CT | Not subsidized | 137.20 (87.16 – 187.22) |
| Endoscopy | Not subsidized | 44.39 (32.28 – 64.56) |
| Biopsy | Not subsidized | 64.56 (48.42 – 80.7) |
| Therapeutic | ||
| Annual cost of tenofovir | Not subsidized | 260.50 (145.26 – 290.52) |
a1 GHS = USD 0.1614 at the time of data collection